Progenics Pharmaceuticals is back to a key resistance level, and
one investor is bracing for a pullback.
optionMONSTER's Depth Charge monitoring program detected the
purchase of 1,000 May 9 puts for $0.38 and the of an equal number
of May 11 calls for $0.63. Volume was more than twice open interest
at both strikes.
The trade resulted in a credit of $0.25 and ensures the investor a
minimum price of $9.25 on PGNX in the event of a pullback. He or
she also agreed to accept a maximum selling price of $11.25 if the
stock closes at or above $11 on expiration. That's roughly the same
level where it peaked in late 2008 and early 2009, which could be
leading some chart watchers to believe that it will continue to
hold the shares in check.
PGNX fell 0.47 percent to $10.63 yesterday but is up more than 60
percent in the last six months. The company's only drug on the
market is Relistor, a constipation treatment for patients using
Known as a
, yesterday's option transaction is a common strategy when
investors think a stock is due for a pause but don't want to exit
their position. (See our
section for more hedging ideas.)
Overall option volume was 35 times greater than average in the
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.
Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.